Insider · CIK 0001601364

Advent Life Sciences LLP

Reports to the SEC for 2 companies · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001601364

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-11-02	Axonics, Inc.C Conversion	Former 10% Owner	CConversion	+43.8K sh	—	—	43,822
2018-11-02	Axonics, Inc.C Conversion	Former 10% Owner	CConversion	+1.23M sh	—	—	1,275,000
2018-11-02	Axonics, Inc.C Conversion	Former 10% Owner	CConversion	+14.4K sh	—	—	1,289,412
2018-11-02	Axonics, Inc.C Conversion	Former 10% Owner	CConversion	+405K sh	—	—	1,694,349
2018-11-02	Axonics, Inc.Series B-2 Preferred StockC Conversion	Former 10% Owner	CConversion	−36.5K sh	—	—	0
2018-11-02	Axonics, Inc.Series B-2 Preferred StockC Conversion	Former 10% Owner	CConversion	−1.03M sh	—	—	0
2018-11-02	Axonics, Inc.Series C Preferred StockC Conversion	Former 10% Owner	CConversion	−12K sh	—	—	0
2018-11-02	Axonics, Inc.Series C Preferred StockC Conversion	Former 10% Owner	CConversion	−337K sh	—	—	0
2015-01-22	Aravive, Inc.P Purchase	Affiliate of Director	PPurchase	+55K sh	$17.25	+$949K	2,271,558
2015-01-22	Aravive, Inc.P Purchase	Affiliate of Director	PPurchase	+55K sh	$17.25	+$949K	2,271,558
2014-03-26	Aravive, Inc.C Conversion	Affiliate of Director	CConversion	+1.26M sh	—	—	1,258,086
2014-03-26	Aravive, Inc.C Conversion	Affiliate of Director	CConversion	+489K sh	—	—	1,747,339
2014-03-26	Aravive, Inc.C Conversion	Affiliate of Director	CConversion	+177K sh	—	—	1,924,152
2014-03-26	Aravive, Inc.C Conversion	Affiliate of Director	CConversion	+78.2K sh	—	—	2,002,380
2014-03-26	Aravive, Inc.C Conversion	Affiliate of Director	CConversion	+154K sh	—	—	2,156,558
2014-03-26	Aravive, Inc.P Purchase	Affiliate of Director	PPurchase	+60K sh	$21.00	+$1.26M	2,216,558
2014-03-26	Aravive, Inc.Warrants to Purchase Series B Preferred StockX Exercise of In-Money	Affiliate of Director	XExercise of In-Money	−506K sh	—	—	0
2014-03-26	Aravive, Inc.Series B Convertible Preferred StockX Exercise of In-Money	Affiliate of Director	XExercise of In-Money	+506K sh	—	—	14,468,020
2014-03-26	Aravive, Inc.Series B Convertible Preferred StockC Conversion	Affiliate of Director	CConversion	−14.5M sh	—	—	0
2014-03-26	Aravive, Inc.Series C Convertible Preferred StockC Conversion	Affiliate of Director	CConversion	−5.63M sh	—	—	0
2014-03-26	Aravive, Inc.Series D-1 Convertible Preferred StockC Conversion	Affiliate of Director	CConversion	−2.03M sh	—	—	0
2014-03-26	Aravive, Inc.Series D-2 Convertible Preferred StockC Conversion	Affiliate of Director	CConversion	−900K sh	—	—	0
2014-03-26	Aravive, Inc.Series E Convertible Preferred StockC Conversion	Affiliate of Director	CConversion	−1.77M sh	—	—	0

Recent filings

Accepted (ET)
Nov 24
Advent Life Sciences LLP0000899243-18-028107
SEC(opens sec.gov)
Jan 264
Versartis, Inc.0001601364-15-000001
SEC(opens sec.gov)
Jan 264/A
Versartis, Inc.0001601364-15-000002
SEC(opens sec.gov)
Mar 274
Versartis, Inc.0001209191-14-023493
SEC(opens sec.gov)

Companies

Address

158 NORTH GOWER STREET

LONDON, X0, NW1 2ND